The Breakthrough Artist Fellowship
Artists Futures Fund: Supporting the Next Generation of Artists
The Bukhman Foundation has partnered with Artists Futures Fund (AFF) to award the 2025/26 Breakthrough Artist Fellowship to one talented emerging visual artist, offering dedicated support to advance their creative career. AFF’s fellowship programme supports talented emerging artists facing significant economic, social, cultural, physical and mental health barriers, helping them build sustainable careers in the visual arts. The Breakthrough Artist Fellowship provides an unrestricted bursary, studio space, mentorship, networking, exhibitions, and professional development opportunities during the critical transition to professional practice where support is often scarce.
About Artists Futures Fund
Artists Futures Fund, an independent charity founded in 1810 and formerly known as the Artists’ Benevolent Fund, supports talented emerging visual artists who face significant socio-economic and health barriers to pursuing creative careers. Through an annual Artist Fellowship programme delivered in partnership with selected education and cultural organisations across England and Wales, AFF aims to remove systemic barriers and help emerging artists build sustainable creative careers. Their core mission to open doors to diverse and exciting futures in the arts ensuring the arts remain accessible to individuals traditionally excluded from the sector.
Images
Anne-Marie Gallares 25-26 AFF Artist Fellow
Heidi Lucca-Redcliffe 25-26 AFF Artist Fellow
You might also be interested in
See all
Bukhman Foundation announces £3 million commitment to New Curators
Supporting the next generation of curators through access to training and international exchange opportunities.
Never the Same by Mohammed Z Rahman at Tate Britain
A new Art Now display as part of Tate Britain’s programme of free contemporary exhibitions, supported by the Bukhman Foundation.
New Website for the Bukhman Centre at the University of Oxford
A new online platform connecting researchers, patients, and families to accelerate collaborative research in Type 1 Diabetes.